Several registry-based randomised clinical trials supported by UCR were presented and discussed at the European Society of Cardiology meeting in late August (ESC Congress 2017). Examples are:
Another trial was presented at the American College of Cardiology ACC.17: 66th Annual Scientific Session & Expo in March:
iFR-guided strategy delivers consistent patient outcomes to an FFR-guided strategy (iFR-SWEDEHEART)
These studies are published in the New England Journal of Medicine:
- Oxygen Therapy in Suspected Acute Myocardial Infarction
- Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
- Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI
UCR is proud to contribute to increased health in Sweden and the rest of the world.